ASCO: Ovarian Suppression & #43; Tamoxifen Ups Breast CA Survival
TUESDAY, June 5, 2018 -- The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published online June 4 in the New England...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Pharmaceuticals | Study | Tamoxifen | Women